Cerebral ischemia-reperfusion aggravated cerebral infarction injury and possible differential genes identified by RNA-Seq in rats

Brain Res Bull. 2020 Mar:156:33-42. doi: 10.1016/j.brainresbull.2019.12.014. Epub 2019 Dec 23.

Abstract

Numerous studies have shown that local excessive inflammatory response in brain tissue was an important pathogenesis of secondary injury following cerebral ischemia-reperfusion (I/R). However, the inflammatory-related targets and pathways after cerebral I/R injury are still unclear. This study was to investigate possible targets and mechanisms after cerebral I/R injury. Rats were subjected to transient or permanent middle cerebral artery occlusion (MCAO). Neurological deficit scores test was used to evaluate neurological function. Cerebral infarction was evaluated by MRI, TTC staining and Nissl staining. Microglia activation was detected by immunofluorescence using Iba-1 antibody. Inflammatory factors were detected by ELISA assay. RNA-sequencing transcriptome analysis was processed and the differential genes were verified by real-time quantitative PCR (qPCR) and western blotting. The results showed that neurological function of rats in I/R group was more severe than that in I group on the 7th after cerebral I/R. Therefore, the differences between cerebral ischemia and cerebral I/R for 7 days were studied in further study. The results showed that the levels of pro-inflammatory factors in I/R group were higher and the levels of anti-inflammatory factors were lower than those in I group. KEGG pathway and gene network enrichment analysis revealed that some common differential up- and down-regulated genes were involved in most of significant pathways. These common differential up-regulated genes belonged to TLR4/MYD88 inflammatory signaling pathway and common differential down-regulated genes belonged to HRAS/RAF1 neurotrophic signaling pathway. Interestingly, according to the genetic interaction analysis of string database, these up-regulated differential genes might promote the development of inflammation, while the down-regulated differential genes might inhibit the development of inflammation. Furthermore, qPCR and WB results verified that these pro-inflammatory genes in the I/R group were higher than those in the I group, while possible anti-inflammatory genes in the I/R group were lower than those in the I group. It is concluded that TLR4/MYD88 inflammatory signaling pathway and HRAS/RAF1 neurotrophic signaling pathway may play different roles after cerebral I or I/R and may be therapeutic targets for stroke recovery.

Keywords: Cerebral ischemia; Cerebral ischemia reperfusion; Neuroinflammation; RNA-seq.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Brain / metabolism
  • Brain Injuries / complications
  • Brain Ischemia / genetics*
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Disease Models, Animal
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / genetics
  • Male
  • Myeloid Differentiation Factor 88 / genetics
  • Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-raf / genetics
  • RNA-Seq
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / genetics*
  • Signal Transduction / physiology
  • Stroke / complications
  • Toll-Like Receptor 4 / genetics
  • ras Proteins / genetics

Substances

  • Hras protein, rat
  • Myd88 protein, rat
  • Myeloid Differentiation Factor 88
  • Oncogene Proteins
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • Proto-Oncogene Proteins c-raf
  • Raf1 protein, rat
  • ras Proteins